Use of HL-60 Cell Line To Measure Opsonic Capacity of Pneumococcal Antibodies
Open Access
- 1 January 2005
- journal article
- review article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 12 (1) , 19-27
- https://doi.org/10.1128/cdli.12.1.19-27.2005
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- Multilaboratory Evaluation of a Viability Assay for Measurement of Opsonophagocytic Antibodies Specific to the Capsular Polysaccharides of Streptococcus pneumoniaeClinical and Vaccine Immunology, 2003
- Efficiency of a Pneumococcal Opsonophagocytic Killing Assay Improved by Multiplexing and by Coloring ColoniesClinical and Vaccine Immunology, 2003
- Chromogenic Assay Measuring Opsonophagocytic Killing Capacities of Antipneumococcal AntiseraClinical and Diagnostic Laboratory Immunology, 2001
- Comparison of a Classical Phagocytosis Assay and a Flow Cytometry Assay for Assessment of the Phagocytic Capacity of Sera from Adults Vaccinated with a Pneumococcal Conjugate VaccineClinical and Diagnostic Laboratory Immunology, 2001
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free cultureAnnals of Hematology, 1995
- Promyelocytic leukemia cell line, HL-60, produces human hepatocyte growth factorBiochemical and Biophysical Research Communications, 1991
- Myeloid-Antigen Expression in Adult Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1987
- Complement in the Pathophysiology of Human DiseaseNew England Journal of Medicine, 1987
- Replacement of serum by insulin and transferrin supports growth and differentiation of the human promyelocytic cell line, HL-60Experimental Cell Research, 1980